5-(1-((2-(4-Cyclopropylpiperazin-1-Yl)Pyridin-4-Yl)Methyl)-5-Methyl-1H-Pyrazol-3-Yl)-3-(4-(Trifluoromethoxy)Phenyl)-1,2,4-Oxadiazole 5-(1-((2-(4-环丙基哌嗪-1-基)吡啶-4-基)甲基)-5-甲基-1H-吡唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-恶二唑
CAS 1227158-85-1 MFCD327158851
化学结构图
SMILES: Cc1cc(-c2nc(-c3ccc(OC(F)(F)F)cc3)no2)nn1Cc1ccnc(N2CCN(C3CC3)CC2)c1
化学属性
| Mol. Weight | 525.54 |
|---|---|
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name Translation | 5-(1-((2-(4-环丙基哌嗪-1-基)吡啶-4-基)甲基)-5-甲基-1H-吡唑-3-基)-3-(4-(三氟甲氧基)苯基)-1,2,4-恶二唑 |
|---|---|
| Chemical Name | 5-(1-((2-(4-Cyclopropylpiperazin-1-Yl)Pyridin-4-Yl)Methyl)-5-Methyl-1H-Pyrazol-3-Yl)-3-(4-(Trifluoromethoxy)Phenyl)-1,2,4-Oxadiazole |
| Formula | C26H26F3N7O2 |
| Synonym | BAY 872243; BAY872243; BAY-872243; BAY 87-2243; BAY87-2243; BAY-87-2243; |
| IUPAC Name | 1-cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]-piperazine |
| InChIKey | CDJNNOJINJAXPV-UHFFFAOYSA-N |
| InChI | InChI=1S/C26H26F3N7O2/c1-17-14-22(25-31-24(33-38-25)19-2-6-21(7-3-19)37-26(27,28)29)32-36(17)16-18-8-9-30-23(15-18)35-12-10-34(11-13-35)20-4-5-20/h2-3,6-9,14-15,20H,4-5,10-13,16H2,1H3 |
| Canonical SMILES | FC(F)(F)OC1=CC=C(C2=NOC(C3=NN(CC4=CC(N5CCN(C6CC6)CC5)=NC=C4)C(C)=C3)=N2)C=C1 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- BAY 87-2243 is a highly potent and selective inhibitor of hypoxia-induced gene activation, which has antitumor activities by inhibition of mitochondrial complex I. BAY 87-2243 mproves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts. BAY-87-2243 markedly decreased nuclear HIF-1α expression and pimonidazole hypoxic fraction already after 3 days of drug treatment. BAY-87-2243 prior to RT significantly reduced TCD50 from 123 to 100 Gy (p=0.037). Additional BAY-87-2243 application during RT did not decrease TCD50.
